Breaking
Saturday, June 20, 2026

Press Releases

🇪🇺 EMA

EMA news and analysis for pharmaceutical BD, investment, and market access

Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.

Showing 1–12 of 121 articles

Quick answer

Track 121 EMA pharmaceutical press releases and corporate announcements — product launches, trial updates, partnerships, and regulatory milestones. Each story links to company profiles, pipeline programs, and related market intelligence for BD and investor due diligence.

High impact NewsMay 5, 2026

Biotheryx BTX-9341 Phase 1A Results to Be Presented at ESMO Breast Cancer Congress 2026

2 min

Dr. Lukas Schneider
High impact NewsMay 4, 2026

CVRx Enrolls First Patient in BENEFIT-HF Heart Failure Trial Testing Barostim Device

2 min

Sofia Alvarez
High impact NewsMay 4, 2026

Agenus Announces Q1 2026 Financial Report Date for Botensilimab and Balstilimab Cancer Programs

2 min

Dr. Amina Farouk
High impact NewsMay 4, 2026

Oncolytics Biotech Reports Durable Responses with Pelareorep in RAS-Mutant Colorectal Cancer Trial

2 min

Dr. Hannah O'Connor
High impact NewsMay 4, 2026

Takeda's TAK-881 Meets Primary Endpoint in Phase 2/3 Trial for Primary Immunodeficiency Disease

2 min

Oliver Grant
Critical impact NewsMay 4, 2026

Pulse Biosciences Reports 100% Success Rate in Atrial Fibrillation Treatment Trial at Heart Rhythm 2026

2 min

Prof. Marcus Webb
High impact NewsMay 4, 2026

SQ Innovation's Lasix ONYU Subcutaneous Heart Failure Trial Results to Be Presented at Heart Failure 2026

EMA · 2 min

Oliver Grant
High impact NewsMay 4, 2026

Acurx DNA pol IIIC Inhibitors Show Gut Microbiome Preservation in MRSA Treatment Study at ESCMID Global 2026

2 min

Prof. Marcus Webb
Critical impact NewsMay 4, 2026

BioCryst Secures $70M Upfront in European Licensing Deal for Navenibart Hereditary Angioedema Treatment

2 min

Charlotte Meyer
High impact NewsMay 4, 2026

Biosimulation Market to Reach $11.3 Billion by 2031 as Pharmaceutical Companies Accelerate Digital Drug Development

2 min

Dr. Lukas Schneider
High impact NewsMay 4, 2026

GRIN Therapeutics Expands Phase 3 Beeline Study for Radiprodil to Europe for GRIN-NDD Treatment

2 min

Oliver Grant
High impact NewsMay 4, 2026

Nuvation Bio's IBTROZI Generates $18.5M Revenue in Q1 2026, Shows Strong First-Line Adoption in ROS1+ NSCLC

2 min

Prof. Marcus Webb

Frequently asked questions

What counts as a press release on NovaPharmaNews?

Corporate announcements from pharma and biotech sponsors — FDA/EMA milestones, trial initiations, financing, licensing deals, and product launches — tagged to the press releases topic and cross-linked to company entity profiles where available.

How is this different from drug approval news?

Drug approval coverage focuses on regulatory decisions and label changes. Press releases capture sponsor-issued announcements, which may precede or supplement formal agency actions.

Can I find press releases by company?

Open any article to see linked company names, then follow through to the company directory profile for pipeline, drugs, patents, and related news.